IMM 21.8% 34.0¢ immutep limited

endpoints for immunotherapy, page-10

  1. 1,232 Posts.
    lightbulb Created with Sketch. 95
    The first one approved by FDA was provenge By Dndreon ,a similar PFS at ph2 to cvac and a similar dendritic treatment focussing on muc1 secreting tumours.
    OS proved to be vey good and hence FDA approval but it was a very bumpy ride to approval. Just look at dendreon's chart over the years leading to approval.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
-0.095(21.8%)
Mkt cap ! $486.6M
Open High Low Value Volume
39.0¢ 40.0¢ 23.0¢ $12.41M 38.82M

Buyers (Bids)

No. Vol. Price($)
18 255187 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 37442 4
View Market Depth
Last trade - 14.13pm 27/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.